Department of General Surgery, San Salvatore Hospital; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Eur Rev Med Pharmacol Sci. 2021 Jun;25(12):4317-4324. doi: 10.26355/eurrev_202106_26139.
The objective of our study is to investigate whether diabetes mellitus could adversely affect post-laparoscopic sleeve gastrectomy (LSG) weight loss.
A retrospectively recorded database of patients who underwent LSG from September 2018 to September 2019 in our Hospital in L'Aquila was analyzed. The post-operative weight loss was evaluated in terms of body mass index (BMI) variation, percentage of excess weight loss (%EWL) and percentage of total weight loss (%TWL). The association between these parameters and diabetes was analyzed at 3 and 6 months of follow-up.
The two groups (patients with and without diabetes) were considered comparable in terms of anthropometric and preoperative parameters. At 3 and 6 months of follow-up, the decrease in BMI resulted to be directly associated with the time and the group. The mean BMI at 3 and 6 months was higher in patients with diabetes. Changes in % EWL and % TWL were similar in both groups.
It is rational to expect a lower weight loss in obese diabetic patients after LSG. This should not be considered as a contraindication to bariatric surgery that, being a metabolic surgery, has as main goal the resolution or improvement of co-morbidities.
本研究旨在探讨糖尿病是否会对腹腔镜袖状胃切除术（LSG）后的减重产生不利影响。
对 2018 年 9 月至 2019 年 9 月期间在拉奎拉医院接受 LSG 的患者进行回顾性记录数据库分析。术后体重减轻通过体重指数（BMI）变化、超重减轻百分比（%EWL）和总体重减轻百分比（%TWL）来评估。在随访 3 个月和 6 个月时分析这些参数与糖尿病之间的关系。
两组（有糖尿病和无糖尿病患者）在人体测量学和术前参数方面具有可比性。在随访 3 个月和 6 个月时，BMI 的下降与时间和组别直接相关。糖尿病患者的平均 BMI 在 3 个月和 6 个月时更高。两组的%EWL 和%TWL 变化相似。
预计肥胖糖尿病患者在 LSG 后体重减轻会较低，这不应被视为减肥手术的禁忌症，因为减肥手术是一种代谢手术，其主要目标是解决或改善合并症。
